{"id":"W3138156139","doi":"10.1136/bjophthalmol-2020-318452","title":"Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions","year":2021,"lang":"en","type":"review","venue":"British Journal of Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":180,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"NIH Clinical Center; National Institutes of Health; Retina UK; Apellis Pharmaceuticals; National Eye Institute; Moorfields Eye Charity; Wellcome Trust; Wellcome; GlaxoSmithKline; Foundation Fighting Blindness; Pfizer","keywords":"Macular degeneration; Medicine; Clinical trial; Bevacizumab; Blindness; Disease; Ranibizumab; Bioinformatics; Intensive care medicine; Ophthalmology; Pathology; Internal medicine; Optometry; Chemotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001115622,0.0002983746,0.003826367,0.0001288046,0.0001366568,0.00006892112,0.00008589165,0.0005822825,0.0003180865],"category_scores_gemma":[0.0004566473,0.0002464869,0.002208537,0.0001516002,0.0001045112,0.0000591217,0.00002440248,0.0004701208,0.000004288006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009697262,"about_ca_system_score_gemma":0.0005122917,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007500494,"about_ca_topic_score_gemma":4.23387e-7,"domain_scores_codex":[0.9956672,0.001632354,0.001964219,0.0003385347,0.0001793975,0.0002183621],"domain_scores_gemma":[0.9974048,0.0006003293,0.001281218,0.0001761505,0.000254474,0.0002830364],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00008986688,0.0006214649,0.0002760682,0.001040644,0.006313795,0.05001681,0.000005857024,4.855201e-8,2.148411e-7,0.00002559086,0.000332246,0.9412774],"study_design_scores_gemma":[0.002735654,0.001127132,0.002202186,0.005319684,0.01686294,0.3128868,0.000008177041,6.511922e-7,1.643122e-7,0.0001384622,0.6585841,0.0001341021],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001774417,0.9950701,0.000007745352,0.0001233864,0.001592562,0.0009929986,0.000244229,0.000006488687,0.0001880887],"genre_scores_gemma":[0.0001378092,0.9949202,0.0007117742,0.00003205381,0.00193919,0.00007839072,0.0005238435,0.00005708245,0.001599676],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9411433,"threshold_uncertainty_score":0.9999987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1996306895202405,"score_gpt":0.4914524664855376,"score_spread":0.2918217769652971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}